[2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride
C20H21Cl2N5O — CID 120802047
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride
[2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride (PubChem CID 120802047) has the molecular formula C20H21Cl2N5O and a molecular weight of 418.33 g/mol. Its IUPAC name is [2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride.
Molecular Properties
| Compound Name | [2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride |
|---|---|
| PubChem CID | 120802047 |
| Molecular Formula | C20H21Cl2N5O |
| Molecular Weight | 418.33 g/mol |
| Exact Mass | 417.11 |
| IUPAC Name | [2-(3-chlorophenyl)piperazin-1-yl]-[2-methyl-4-(1,2,4-triazol-1-yl)phenyl]methanone;hydrochloride |
| SMILES | Cc1cc(-n2cncn2)ccc1C(=O)N1CCNCC1c1cccc(Cl)c1.Cl |
| InChI | InChI=1S/C20H20ClN5O.ClH/c1-14-9-17(26-13-23-12-24-26)5-6-18(14)20(27)25-8-7-22-11-19(25)15-3-2-4-16(21)10-15;/h2-6,9-10,12-13,19,22H,7-8,11H2,1H3;1H |
| InChIKey | IGBLKKJYPIMTTA-UHFFFAOYSA-N |
| XLogP | 3.44 |
| TPSA | 63.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.33 |
| LogP ≤ 5 | 3.44 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120802047 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.